BC Week In Review | Jun 30, 2014
Company News

Cipla, Hetero Drugs deal

Hetero granted Cipla non-exclusive commercialization rights to Actorise darbepoetin alfa, a biosimilar of Aranesp darbepoetin alfa, in India, where Cipla launched the product to treat anemia caused by chronic kidney disease (CKD). Hetero said a...
Items per page:
1 - 1 of 1